[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:fgfr1-gene":3},{"name":4,"total":5,"recruiting":6,"trials":7},"FGFR1 Gene",3,2,[8,16,23],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07408089","Study of the Kinesin Oral Molecular Degrader BBI-940 in Subjects With Advanced or Metastatic Breast Cancer",[12],"Phase 1","RECRUITING","2026-08-03T03:53:05.241597Z","2026-05-05T02:43:27.518233Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT05009992","Combination Therapy for the Treatment of Diffuse Midline Gliomas",[20],"Phase 2","2026-08-26T02:16:51.982021Z","2026-05-05T02:43:28.301737Z",{"nct_id":24,"title":25,"phases":26,"status":27,"updated_at":28,"content_modified":29},"NCT07393373","Open-Label, Long-Term, Extension Study of Infigratinib in Children With Hypochondroplasia",[20],"ENROLLING_BY_INVITATION","2026-08-26T02:18:58.958025Z","2026-06-16T05:54:07.881623Z"]